Zurich Cantonal Bank’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,036
| Closed | -$1.04M | – | 2971 |
|
|
2021
Q3 | $1.04M | Buy |
6,036
+15
| +0.2% | +$1.96K | 0.01% | 914 |
|
|
2021
Q2 | $756K | Buy |
6,021
+20
| +0.3% | +$2.52K | ﹤0.01% | 993 |
|
|
2021
Q1 | $814K | Sell |
6,001
-852
| -12% | -$110K | ﹤0.01% | 952 |
|
|
2020
Q4 | $877K | Buy |
6,853
+1,410
| +26% | +$165K | 0.01% | 1004 |
|
|
2020
Q3 | $613K | Hold |
5,443
| – | – | ﹤0.01% | 1004 |
|
|
2020
Q2 | $519K | Buy |
5,443
+1,753
| +48% | +$169K | ﹤0.01% | 989 |
|
|
2020
Q1 | $332K | Buy |
3,690
+357
| +11% | +$27.8K | ﹤0.01% | 1002 |
|
|
2019
Q4 | $177K | Buy |
3,333
+375
| +13% | +$17.1K | ﹤0.01% | 1408 |
|
|
2019
Q3 | $117K | Hold |
2,958
| – | – | ﹤0.01% | 1538 |
|
|
2019
Q2 | $122K | Hold |
2,958
| – | – | ﹤0.01% | 1505 |
|
|
2019
Q1 | $138K | Buy |
2,958
+356
| +14% | +$15.6K | ﹤0.01% | 1385 |
|
|
2018
Q4 | $113K | Buy |
2,602
+386
| +17% | +$19.3K | ﹤0.01% | 1540 |
|
|
2018
Q3 | $127K | Buy |
2,216
+588
| +36% | +$28.9K | ﹤0.01% | 1579 |
|
|
2018
Q2 | $79K | Hold |
1,628
| – | – | ﹤0.01% | 1805 |
|
|
2018
Q1 | $64K | Hold |
1,628
| – | – | ﹤0.01% | 1891 |
|
|
2017
Q4 | $69K | Buy |
1,628
+604
| +59% | +$22.7K | ﹤0.01% | 1819 |
|
|
2017
Q3 | $38K | Hold |
1,024
| – | – | ﹤0.01% | 1981 |
|
|
2017
Q2 | $31K | Hold |
1,024
| – | – | ﹤0.01% | 2064 |
|
|
2017
Q1 | $27K | Hold |
1,024
| – | – | ﹤0.01% | 2188 |
|
|
2016
Q4 | $26K | Hold |
1,024
| – | – | ﹤0.01% | 2163 |
|
|
2016
Q3 | $37K | Buy |
1,024
+197
| +24% | +$6.53K | ﹤0.01% | 1845 |
|
|
2016
Q2 | $28K | Hold |
827
| – | – | ﹤0.01% | 1852 |
|
|
2016
Q1 | $22K | Hold |
827
| – | – | ﹤0.01% | 1986 |
|
|
2015
Q4 | $40K | Buy |
827
+540
| +188% | +$19.4K | ﹤0.01% | 1568 |
|
|
2015
Q3 | $7K | Buy |
+287
| New | +$8.63K | ﹤0.01% | 2315 |
|
Zurich Cantonal Bank's XLRN Position: Q4 2021 in Review
Zurich Cantonal Bank sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,036 shares — an estimated $1.04M sold.
Zurich Cantonal Bank first reported a position in XLRN in Q3 2015 and held it in 25 quarters. The position peaked at $1.04M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Zurich Cantonal Bank reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Zurich Cantonal Bank sold 6,036 Acceleron Pharma shares in Q4 2021, an estimated $1.04M.
- Zurich Cantonal Bank first reported a position in Acceleron Pharma in Q3 2015 and held it in 25 quarters.
- Zurich Cantonal Bank's Acceleron Pharma position peaked at $1.04M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Zurich Cantonal Bank's 13F filing for Q4 2021, filed 1 Feb 2022.